Boston Scientific announces agreement to acquire Penumbra, Inc.
Acquisition to expand Boston Scientific’s cardiovascular portfolio and further address increasing prevalence of vascular diseases
Acquisition to expand Boston Scientific’s cardiovascular portfolio and further address increasing prevalence of vascular diseases